SIA
MESO

Sit Investment Associates’s Mesoblast MESO Stock Holding History

Sit Investment Associates’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37,438
Closed -$1.39M – 540
2020
Q3 		$1.39M Buy
37,438
+19,313
+107% +$605K 0.04% 320
2020
Q2 		$413K Buy
+18,125
New +$388K 0.01% 384

Other funds holding MESO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Sit Investment Associates's MESO Position: Q4 2020 in Review

Sit Investment Associates sold out of Mesoblast (MESO) in Q4 2020, closing a stake of 37,438 shares — an estimated $1.39M sold.

Sit Investment Associates first reported a position in MESO in Q2 2020 and held it in 2 quarters. The position peaked at $1.39M in Q3 2020. 53 funds tracked by Wall St. Rank hold MESO as of Q4 2020.

  • Sit Investment Associates reported no remaining Mesoblast position as of Q4 2020 after selling out during the quarter.
  • Sit Investment Associates sold 37,438 Mesoblast shares in Q4 2020, an estimated $1.39M.
  • Sit Investment Associates first reported a position in Mesoblast in Q2 2020 and held it in 2 quarters.
  • Sit Investment Associates's Mesoblast position peaked at $1.39M in Q3 2020.
  • 53 funds tracked by Wall St. Rank held Mesoblast as of Q4 2020.

Based on Sit Investment Associates's 13F filing for Q4 2020, filed 11 Feb 2021.